Publications Archives - Alira Health | Alira Health

Home > Education Hub > Publications

Publications May 27, 2022

The Impact of Chip Shortage on the MedTech Sector and RAS Players

Discover the three factors driving the chip shortage, the impact, and what’s next for Robotic and MedTech industry at large.

CDMO MedTech Robotcs

Publications April 20, 2022

White Paper: Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective

In this white paper, we will explore wide range of new therapies we term “Next Generation Therapies” and challenges related to them.

Publications April 8, 2022

Cheat Sheet: MDCG Guidance on Medical Device Classification

Assigning the proper class to a medical device (MD) is one of the most important activities carried out by a manufacturer. Read Alira Health's cheat sheet MDCG Guidance on Medical Device(...)

MedTech Regulatory

Publications March 31, 2022

The FDA’s Project Orbis Can Speed up the Delivery of Your New Oncology Drug to Global Markets

Are you developing an oncology drug? Project Orbis, a program coordinated by the U.S. Food and Drug Administration (FDA), allows you to register your product in several countries with(...)

Pharma Regulatory

Publications March 31, 2022

Real-World Evidence: Five Facts You Need to Know

Learn more about RWD and its future challenges for Europe, we asked Romain Finas, Vice President of Real-World Evidence (RWE) at Alira Health, to share five facts that you need to know about it.

Market Access RWE

Publications March 28, 2022

The 2022 MedTech Contract Manufacturing Report

Read our report on the trends detected during 2022 and their meaning for medical device CDMOs and their capital sponsors.

Publications March 25, 2022

Early Access Programs: Keys to Success

Discover Alira Health’s top five recommendations to building a successful Early Access Programs (EAP).

Publications March 22, 2022

Biometrics: Industry State of Affairs

We spoke with Katell Bernois, Director of Statistical Consulting at Alira Health, to understand the key trends that are changing the biometrics industry.

Publications March 17, 2022

Next Generation Therapies: Access, Pricing, and Challenges

Learn more about Next Generation Therapies that have the potential to disrupt the biopharmaceutical environment.

Load more

Latest from Alira Health

Events May 27, 2022

PSI 2022 Conference

We are pleased to announce that this year we will be joining PSI 2022 Conference, the principal annual event for statisticians in the pharmaceutical industry, as sponsors, exhibitors, and delegates.

Events May 19, 2022

DIA 2022 Global Annual Meeting

We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.

Biometrics Clinical Regulatory

Events May 19, 2022

Patient Centricity & Engagement 2022

Join us on the 24th of May in London to discuss next-level strategies to embed patients at the heart of organisational decision making.

Patient Engagement

Multimedia May 19, 2022

Fireside Chat: Latest Developments in Oncology Supportive Care

In this fireside chat, we sit down with two medical experts in oncology and discuss some of the fascinating developments that are happening in the oncology supportive care field.

Multimedia May 10, 2022

VacciTalks: Behind the Scenes: Challenging Race of Vaccine Development

Join the 2nd episode of VacciTalks where together with vaccine expert Roberto Camerini we will peek behind the scenes of vaccine development and get an insider look at the difficulties,(...)

Multimedia April 28, 2022

Alira Health’s Transformation Talks: Real-World Data to Support HTAs in Europe

Learn more about RWD as a support in HTAs and its direct impact on HTAs budgets, results, and even patient outcomes by listening to this episode of Transformation Talks.

Clinical Market Access RWE

News May 11, 2022

Alira Health Acquires RedCrow, an Equity Crowdfunding Platform for Healthcare Startups

We acquired RedCrow, an alternative investment platform that provides individual investors with easy access to expert-vetted healthcare start-ups. The financial terms of the transaction(...)

MedTech Patient Engagement Pharma

News April 5, 2022

Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia

We acquired a full-service Contract Research Organization (CRO), Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and(...)

Clinical MedTech Patient Engagement Pharma Regulatory Research & Development

News March 22, 2022

Alira Health and HTAi Collaborate to Develop a Multi-Stakeholder Value Assessment Framework for Robotic-Assisted Surgery & Digital Health

Learn more about the new evidence-based guidance on HTA for Robotic-Assisted Surgery and Digital Health Technologies.

View all Events